Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer

Prostate

Volumn 31, Issue 1, 1997, Pages 42-46

  Asbell, Sucha O ^a   Vijayakumar, Srinivasan ^b,c  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MICHAEL REESE HOSPITAL   (United States)

Author keywords

prognosis; prostate cancer; prostate specific antigen; racial ethnic differences

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SOCIOECONOMICS; STATISTICAL ANALYSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 0030900551     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970401)31:1<42::AID-PROS7>3.0.CO;2-K     Document Type: Article

References (25)

1. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. Ca Cancer J Clinicians 45:8-30, 1995.
2. Partin AW, Oesterling JE: The clinical usefulness of prostate specific antigen: Update 1994. J Urol 152:1358-1368, 1994.
3. Andriole GL: Serum prostate-specific antigen: The most useful tumor marker. J Clin Oncol 10:1205-1207, 1992.
4. Gittes RF: Prostate-specific antigen. N Engl J Med 317: 954-955, 1987.
5. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141:1076-1083, 1989.
6. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-915, 1987.
7. Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan AM: Localized prostate cancer: Use of serial prostate-specific antigen measurements during radiation therapy - an update. Onkologie 17:578-585, 1994.
8. Vijayakumar S, Karrison T, Weichselbaum RR, Chan SK, Quadri SF, Awan A: Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev 541-545, 1992.
9. Lee F, Littrup PJ, Loft-Christensen L, Kelly B Jr, McHugh TA, Siders DB, Mitchell AE, Newby JE: Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer. Cancer 70: 211-220, 1992.
10. Mebane C, Gibbs Y, Horm J: Current status of prostate cancer in North American black males. J Natl Med Assoc 82:782-783, 1990.
11. Bang KM, White JE, Cause BL, Leffall L Jr: Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer 61:1255-1261, 1988.
12. Dayal HH, Polissar L, Dahlberg S: Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. J Natl Cancer Inst 74:1001-1006, 1985.
13. Fraumeni J Jr: The face of cancer in the United States. Hosp Pract 18:81-85, 1983.
14. Jackson MA, Ahluwalia BS, Herson J, Heshmat MY, Jackson AG, Jones GW, Kapoor SK, Kennedy J, Kovi J, Lucas AO, Nkposong EO, Olisa E, Williams AO: Characterization of prostatic carcinoma among blacks: A continuation report. Cancer Treat Rep 61:167-172, 1977.
15. Lee JY, Soong SJ: Cancer mortality in the South, 1950 to 1980. South Med J 83:185-190, 1990.
16. Guinan PD, Wiggishoff CC, Rotkin ID, Chmiel JS, Sylvester J, Cunningham MP: Prostate cancer in Illinois. Ill Med J 166:341-345, 1984.
17. Kovi J: Carcinoma of the prostate: A disease of black men? J Natl Med Assoc 75:121-122, 1983.
18. Natarajan N, Murphy GP, Mettlin C: Prostate cancer in blacks: An update from the American College of Surgeons' patterns of care studies. J Surg Oncol 40:232-236, 1989.
19. Dale W, Vijayakumar S, Lawlor E, Merrell K: Prostate cancer, race, and socioeconomic status: Inadequate adjustment for social factors in assessing racial differences. Prostate 29:271-281, 1996.
20. Bal DG: Guest editorial: Cancer in African Americans. CA Cancer J Clin 42:5-6, 1992.
21. Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S: Prostate specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. The Cancer Journal from Scientific American 2:225-233, 1996.
22. Snedecor GW, Cochran WG: "Statistical Methods." 7th Ed. Ames, IA: Iowa State University Press, 1980.
23. McNeal JE, Villers AA, Red wine EA, Freiha FS: Histologie differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66:1225-1233, 1990.
24. Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, McLeod DG: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 274:1277-1281, 1995.
25. Radiation Therapy Oncology Group: RTOG 94-12. A prospective study to determine possible racial and socioeconomic differences in pre-treatment PSA levels in patients with local-regional carcinoma of the prostate. Philadelphia, PA